Introduction
Allogeneic hematopoietic cell transplantation has long been recognized as a curative treatment choice for a variety of hematopoietic malignancy diseases 1 . Mature T cells contained in the graft play a critical role in the success of this treatment because depletion of mature T cells from the graft significantly increases the risk of graft failure, leukemia relapse and delays immune reconstitution 2 . On the other hand, mature T cells also mediate graft-vs.-host disease (GVHD) 3 , which is a potentially fatal side effect associated with allogeneic hematopoietic cell transplantation. Depletion of all mature T cells from the graft is very effective in preventing GVHD but at the same time lose all mature T cell-mediated beneficial effects 2 . The major challenge is how to transfer allogeneic T cell immunity without causing GVHD 4 .
Alloreactive T cells, which represent only a small portion of T cells 5, 6 , are responsible for induction of GVHD 3 . Theoretically, selective depletion of alloreactive T cells may prevent GVHD while preserving other immune functions. Indeed, GVHD has been successfully prevented without impairing other immune functions in several animal models mainly by targeting activation markers after host-activated T cells are activated ex vivo [7] [8] [9] [10] [11] or in vivo 12 . Likewise, similar strategies were also successfully tested in vitro in humans [13] [14] [15] [16] [17] . However, only a few of these strategies 18, 19 have been explored in human trials so far probably due to the complexity of these published approaches. Development of simpler and effective approaches to transfer allogeneic T cell immunity without causing GVHD is still highly desirable 4 .
For personal use only. on October 17, 2017 . by guest www.bloodjournal.org From Naïve T cells (CD62L + ) are T cells that have never encountered antigens specific for their T cell receptor [20] [21] [22] . Memory/activated T cells (CD62L -or CD62L + ) are T cells which have previously been exposed to their corresponding antigens 20, 21 . If a donor has never encountered the host alloantigens, GVHD-inducing host-reactive T cells should be contained in naïve T cell compartment. If this hypothesis is correct as suggested by several published studies 5, 23 , CD62L -T cells, which are devoid of naïve T cells and represent a subset of memory/activated T cells [20] [21] [22] [24] [25] [26] [27] , should not be able to induce GVHD.
In the current study, we compared the ability of CD62L -T cells to induce GVHD with unseparated as well as CD62L + T cells (represent naïve and a subset of memory/activated T cells 20, 21 ). Moreover, the effects of CD62L -T cells on T cell reconstitution and whether CD62L -T cells can carry functional anti-tumor immunity were also examined. Immunization. C57BL/6 mice were injected with 5×10 7 irradiated (100 Gy) BCL1 cells from spleens of BCL1-bearing BALB/c mice intraperitoneally. The primed animals were used 12 to 14 days after immunization.
Material and Methods
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Cell separation. T cells were first negatively selected from spleen cells by using antimajor histocompatibility complex (MHC) Class II (Ia), CD11a and DX5 microbeads (Miltenyi Biotec). Anti-CD62L microbeads (Miltenyi Biotec) was then used to separate purified T cells into CD62L + and CD62L -fractions. The purity of the cell population was always checked by flow cytometry after cell separation. A typical cell separation was shown in Figure 1 . The responder cell doses were always adjusted based on T cell content. 
MLR assay.
Results
Effects of CD62L
-T cells from unprimed mice on GVHD. We first tested the ability of and Mls-3 antigens, which are present in recipient C3H/HeJ mice but are absent in the donor C57BL/6 mice, were deleted in CD62L -T cell recipients ( Figure 8C ). However, clonal anergy might also be involved because Vβ3 + T cells, which also recognise Mls-2 and Mls-3 antigens, were not deleted in CD62L -T cell recipients ( Figure 8C ).
Establishment of antigen-specific immune tolerance further demonstrated the lack of GVHD in CD62L -T cell recipients. Figure 6 ) suggests that there is little if any activity of regulatory cells. These data suggest that lack of ability of CD62L -T cells to induce GVHD is not due to altered regulatory activity. Another possible explanation for the lack of GVHD is the decreased ability of T cells to persist in vivo 45 . This is not the case for CD62L -T cells since CD62L -T cells persisted more than 70 days after transplantation ( Figure 5B&5F ). Expression of CD62L is required for T cells to efficiently recirculate between blood and lymph node 46 .
Discussion
CD62L engages ligands expressed on high endothelial venules and trigger a signaling cascade, leading to firm arrest and lymphocyte tranmigration into the lymph node 47 .
Therefore, lack of GVHD associated with CD62L -T cells is also possible due to the inability of CD62L -T cells to home to secondary lymphoid organs 46 . However, this mechanism can not explain the low proliferative activity of CD62L -T cells from unprimed mice in response to alloantigens in vitro. Taken together, the lower ability of CD62L -T cells to induce GVHD is most likely a result of lower frequencies of host antigen-specific T cells found in CD62L -T cells. These results seem to conflict with the results from umbilical cord blood transplantation [48] [49] [50] , in which reduced incidence of GVHD was observed despite the fact that cord blood T cells contain much more naïve T cells compared with adult blood 51, 52 . However, the lower rate of GVHD observed in 
